euroPCR 2012.

The most relevant news daily report fromthe EuroPCR congress, held in Paris from the15th to 18th May 2012.

To close a brilliant event, EuroPCR authorities invited the presidents of the European and American societies represented in Paris to a gala tribute dinner at La Maison de l’ Amérique Latine, a magnificent mansion built with the support of Latin American ambassadors in the mid-20th century. The former presidents of the American College of Cardiology, Dr. Spencer King and Dr. David Holmes, also made the honors. Dr. Oscar Mendiz was there representing SOLACI, for Latin America.

If you cannot view the articles, click here

Previous article
Next article

More articles by this author

EuroPCR 2024

Here are the most important scientific articles of the EuroPCR 2024 Scientific Sessions. If you cannot view the articles, click here

ACC 2024

Here are the most important scientific articles of the ACC 2024 Scientific Sessions. If you cannot view the articles, click here

AHA 2023

Here are the most important scientific articles of the AHA 2023 Congress. If you cannot view the articles, click here

TCT 2023

Here are the most important scientific articles of the TCT 2023 Congress. If you cannot view the articles, click here

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Related Articles

SOLACI Sessionsspot_img

Recent Articles

COILSEAL: Use of Coils in Percutaneous Coronary Intervention, Useful for Complication Management?

The use of coils as vascular closing tool has been steadily expanding beyond its traditional role in neuroradiology into coronary territory, where it remains...

Treatment of In-Stent Restenosis in Small Vessels with Paclitaxel-Coated Balloons

Coronary artery disease (CAD) in smaller epicardial vessels occurs in 30% to 67% of patients undergoing percutaneous coronary intervention and poses particular technical challenges....

Contemporary Challenges in Left Atrial Appendage Closure: Updated Approach to Device Embolization

Even though percutaneous left atrial appendage (LAA) closure is generally safe, device embolization – with 0 to 1.5% global incidence – is still a...